News articles about Allscripts Healthcare Solutions (NASDAQ:MDRX) have trended somewhat positive on Saturday, according to Accern Sentiment. The research group scores the sentiment of media coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Allscripts Healthcare Solutions earned a news impact score of 0.18 on Accern’s scale. Accern also assigned news coverage about the software maker an impact score of 45.565897673782 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.
These are some of the news articles that may have impacted Accern Sentiment’s rankings:
- Alliancebernstein LP Has $1.71 Million Stake in Allscripts Healthcare Solutions, Inc. (MDRX) (overnewsmagazine.com)
- Allscripts Healthcare Solutions (NASDAQ:MDRX) Sees Significantly Higher Trading Volume (techkenyot.com)
- How Many Allscripts Healthcare Solutions Inc (NASDAQ:MDRX)’s Analysts Are Bullish? (topactu.net)
- Allscripts Healthcare Solutions (NASDAQ:MDRX) & Press Ganey Holdings (PGND) Financial Review (americanbankingnews.com)
- Allscripts Healthcare Solutions (NASDAQ:MDRX) Closed Much Higher Than Its 50 Day Moving Average – First News 24 (firstnewspaper24.com)
Several analysts have commented on the stock. Morgan Stanley increased their price target on shares of Allscripts Healthcare Solutions from $11.00 to $12.00 and gave the company an “underweight” rating in a research report on Monday, August 7th. Citigroup Inc. increased their price target on shares of Allscripts Healthcare Solutions from $13.00 to $14.00 and gave the company a “neutral” rating in a research report on Monday, August 7th. Zacks Investment Research raised shares of Allscripts Healthcare Solutions from a “sell” rating to a “hold” rating in a research report on Wednesday. BidaskClub raised shares of Allscripts Healthcare Solutions from a “sell” rating to a “hold” rating in a research report on Saturday, June 24th. Finally, Leerink Swann lowered shares of Allscripts Healthcare Solutions from an “outperform” rating to a “market perform” rating and decreased their price target for the company from $15.00 to $13.00 in a research report on Monday, June 19th. One research analyst has rated the stock with a sell rating, ten have assigned a hold rating and nine have assigned a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average price target of $14.66.
Shares of Allscripts Healthcare Solutions (NASDAQ:MDRX) traded up 2.59% during trading on Friday, reaching $12.67. 2,102,061 shares of the company traded hands. The company’s market capitalization is $2.29 billion. The stock’s 50 day moving average is $12.50 and its 200 day moving average is $12.16. Allscripts Healthcare Solutions has a 1-year low of $9.80 and a 1-year high of $13.70.
Allscripts Healthcare Solutions (NASDAQ:MDRX) last issued its quarterly earnings data on Thursday, August 3rd. The software maker reported $0.11 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.15 by $0.04. Allscripts Healthcare Solutions had a negative net margin of 33.56% and a negative return on equity of 54.26%. The firm had revenue of $426.10 million during the quarter, compared to analysts’ expectations of $424.94 million. During the same quarter in the prior year, the firm posted $0.14 EPS. Allscripts Healthcare Solutions’s quarterly revenue was up 10.2% compared to the same quarter last year. On average, analysts forecast that Allscripts Healthcare Solutions will post $0.62 EPS for the current year.
In other Allscripts Healthcare Solutions news, President Richard J. Poulton sold 25,000 shares of the business’s stock in a transaction that occurred on Tuesday, May 16th. The stock was sold at an average price of $12.06, for a total value of $301,500.00. Following the completion of the sale, the president now owns 412,488 shares in the company, valued at $4,974,605.28. The sale was disclosed in a document filed with the SEC, which is available through this link. 0.75% of the stock is currently owned by insiders.
COPYRIGHT VIOLATION NOTICE: This piece of content was posted by StockNewsTimes and is the sole property of of StockNewsTimes. If you are viewing this piece of content on another website, it was copied illegally and reposted in violation of U.S. and international trademark & copyright law. The correct version of this piece of content can be accessed at https://stocknewstimes.com/2017/08/12/allscripts-healthcare-solutions-mdrx-receiving-somewhat-positive-media-coverage-analysis-finds.html.
About Allscripts Healthcare Solutions
Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.
Receive News & Ratings for Allscripts Healthcare Solutions Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions Inc and related companies with MarketBeat.com's FREE daily email newsletter.